[HTML][HTML] Updates on the management of thyroid cancer
The diagnostic modalities, stratification tools, and treatment options for patients with thyroid
cancer have rapidly evolved since the development of the American Thyroid Association …
cancer have rapidly evolved since the development of the American Thyroid Association …
[HTML][HTML] The genomic landscape of thyroid cancer tumourigenesis and implications for immunotherapy
A Singh, J Ham, JW Po, N Niles, T Roberts, CS Lee - Cells, 2021 - mdpi.com
Thyroid cancer is the most prevalent endocrine malignancy that comprises mostly indolent
differentiated cancers (DTCs) and less frequently aggressive poorly differentiated (PDTC) or …
differentiated cancers (DTCs) and less frequently aggressive poorly differentiated (PDTC) or …
[HTML][HTML] Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
S Filetti, C Durante, D Hartl, S Leboulleux, LD Locati… - Annals of …, 2019 - Elsevier
This ESMO Clinical Practice Guideline provides updated state-of-the-art recommendations
on management of thyroid cancer (diagnosis, treatment and follow-up), compiled by a …
on management of thyroid cancer (diagnosis, treatment and follow-up), compiled by a …
Real-world performance of the American Thyroid Association risk estimates in predicting 1-year differentiated thyroid cancer outcomes: a prospective multicenter study …
G Grani, MC Zatelli, M Alfò, T Montesano, M Torlontano… - Thyroid, 2021 - liebertpub.com
Background: One of the most widely used risk stratification systems for estimating individual
patients' risk of persistent or recurrent differentiated thyroid cancer (DTC) is the American …
patients' risk of persistent or recurrent differentiated thyroid cancer (DTC) is the American …
[HTML][HTML] Strategies for radioiodine treatment: what's new
C Sparano, S Moog, J Hadoux, C Dupuy, A Al Ghuzlan… - Cancers, 2022 - mdpi.com
Simple Summary Radioactive iodine treatment is the oldest targeted therapy for
differentiated thyroid cancer. It can be used for normal thyroid remnant ablation (in order to …
differentiated thyroid cancer. It can be used for normal thyroid remnant ablation (in order to …
Low‐risk papillary thyroid microcarcinoma: Optimal management toward a more conservative approach
V Ramundo, M Sponziello, R Falcone… - Journal of surgical …, 2020 - Wiley Online Library
The incidence of papillary thyroid microcarcinoma (microPTC) has dramatically increased in
the last decades. Most of these tumors remain small and clinically “silent”, only small number …
the last decades. Most of these tumors remain small and clinically “silent”, only small number …
A data-driven approach to refine predictions of differentiated thyroid cancer outcomes: a prospective multicenter study
Context The risk stratification of patients with differentiated thyroid cancer (DTC) is crucial in
clinical decision making. The most widely accepted method to assess risk of …
clinical decision making. The most widely accepted method to assess risk of …
Lack of association between obesity and aggressiveness of differentiated thyroid cancer
G Grani, L Lamartina, T Montesano, G Ronga… - Journal of …, 2019 - Springer
Purpose Aim of this study was to evaluate the association between body mass index (BMI)
and aggressive features of differentiated thyroid cancer (DTC) in a prospective cohort …
and aggressive features of differentiated thyroid cancer (DTC) in a prospective cohort …
[HTML][HTML] Antitumor effect of various phytochemicals on diverse types of thyroid cancers
HJ Shin, KA Hwang, KC Choi - Nutrients, 2019 - mdpi.com
Thyroid cancers developed from the tissues of the thyroid gland are classified into papillary
(PTC), follicular (FTC), medullary (MTC), and anaplastic thyroid cancer (ATC). Although …
(PTC), follicular (FTC), medullary (MTC), and anaplastic thyroid cancer (ATC). Although …
[HTML][HTML] Multi-omics and management of follicular carcinoma of the thyroid
TE Luvhengo, I Bombil, A Mokhtari, MS Moeng… - Biomedicines, 2023 - mdpi.com
Follicular thyroid carcinoma (FTC) is the second most common cancer of the thyroid gland,
accounting for up to 20% of all primary malignant tumors in iodine-replete areas. The …
accounting for up to 20% of all primary malignant tumors in iodine-replete areas. The …